CYP19A1 and gastroesophageal reflux disease: A 67-year-old female with a past medical history of hypertension, hyperlipidemia, invasive ductal breast carcinoma with lumpectomy treated with aromatase inhibitor and localized intensity-modulated radiation therapy (IMRT) to the left breast (2016), left eye retinal detachment with partial blindness, gastroesophageal reflux disease (GERD), chronic dry cough, and progressive dysphagia presented to our infectious diseases clinic for evaluation of positive T. cruzi infection screening assays after routine blood donation in September 2020.